US5885567A
(en)
*
|
1993-10-22 |
1999-03-23 |
University Of Connecticut |
Treatment of infection in fowl by oral administration of avian interferon proteins
|
GB9700624D0
(en)
|
1997-01-14 |
1997-03-05 |
Danbiosyst Uk |
Drug delivery composition
|
EP1012331B1
(en)
|
1997-07-01 |
2006-03-29 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the delivery of oligonucleotides via the alimentary canal
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US6423334B1
(en)
|
1997-10-01 |
2002-07-23 |
Elan Corporation, Plc |
Composition and method for enhancing transport across gastrointestinal tract cell layers
|
SE9703691D0
(sv)
*
|
1997-10-10 |
1997-10-10 |
Astra Ab |
Pharmaceutical compositions
|
FR2775188B1
(fr)
*
|
1998-02-23 |
2001-03-09 |
Lipha |
Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
EP1080103A4
(en)
*
|
1998-05-21 |
2003-07-02 |
Isis Pharmaceuticals Inc |
COMPOSITIONS AND METHODS FOR NON-PARENTERAL ADMINISTRATION OF OLIGONUCLEOTIDES
|
GB9824604D0
(en)
*
|
1998-11-11 |
1999-01-06 |
Hewlett Healthcare Limited |
Treatment of allergic conditions
|
WO2000033866A1
(en)
*
|
1998-12-04 |
2000-06-15 |
Provalis Uk Limited |
Pharmaceutical compositions containing insulin
|
US20070148228A1
(en)
*
|
1999-02-22 |
2007-06-28 |
Merrion Research I Limited |
Solid oral dosage form containing an enhancer
|
US8119159B2
(en)
*
|
1999-02-22 |
2012-02-21 |
Merrion Research Iii Limited |
Solid oral dosage form containing an enhancer
|
US7658938B2
(en)
|
1999-02-22 |
2010-02-09 |
Merrion Reasearch III Limited |
Solid oral dosage form containing an enhancer
|
AU2681300A
(en)
*
|
1999-02-22 |
2000-09-14 |
Elan Corporation, Plc |
Solid oral dosage form containing an enhancer
|
SE9901272D0
(sv)
*
|
1999-04-09 |
1999-04-09 |
Astra Ab |
New improved formulation
|
US7169889B1
(en)
*
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
EP1712222A3
(en)
*
|
1999-12-23 |
2012-06-20 |
Pfizer Products Inc. |
Pharmaceutical compositions providing enhanced drug concentrations
|
CN1312080A
(zh)
|
2000-02-18 |
2001-09-12 |
日本脏器制药株式会社 |
含有脂肪酸的组合物
|
JP2001240558A
(ja)
*
|
2000-02-29 |
2001-09-04 |
Nippon Suisan Kaisha Ltd |
多価不飽和脂肪酸を経粘膜吸収促進剤として含有する固形製剤。
|
KR20030005204A
(ko)
*
|
2000-12-25 |
2003-01-17 |
가부시키가이샤 시세이도 |
교감신경 활성화 향료 조성물
|
US7060675B2
(en)
*
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
US6867183B2
(en)
*
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
JP2004525110A
(ja)
*
|
2001-02-16 |
2004-08-19 |
清水製薬株式会社 |
ムコ多糖類製剤およびその製造法
|
DK1385498T3
(da)
*
|
2001-04-18 |
2008-03-25 |
Prometic Biosciences Inc |
Fedtsyrer som overlevelses- og aktiveringsfaktorer for neutrofiler
|
JP4489356B2
(ja)
|
2001-05-11 |
2010-06-23 |
メリオン リサーチ スリー リミテッド |
浸透促進剤
|
CA2446622C
(en)
*
|
2001-05-11 |
2012-08-14 |
Elan Corporation, Plc |
Isostearic acid salts as permeation enhancers
|
US6713452B2
(en)
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6835802B2
(en)
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US6828297B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7713932B2
(en)
*
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
CA2452056C
(en)
|
2001-07-02 |
2011-11-01 |
Elan Corporation, Plc. |
Compositions of bioactive material particles dispersed in a continuous solid encapsulating material
|
ES2539105T3
(es)
*
|
2001-07-06 |
2015-06-26 |
Asterias Biotherapeutics, Inc. |
Células mesenquimatosas y osteoblastos procedentes de células madre embrionarias humanas
|
US7166571B2
(en)
*
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US6913903B2
(en)
*
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7196059B2
(en)
*
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7312192B2
(en)
*
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
US7030082B2
(en)
*
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
US7700572B2
(en)
*
|
2001-11-02 |
2010-04-20 |
Giuliani International, Ltd. |
SMAD7 inhibitors for the treatment of CNS diseases
|
MY139721A
(en)
*
|
2002-04-19 |
2009-10-30 |
Cpex Pharmaceuticals Inc |
Pharmaceutical composition
|
GB0210397D0
(en)
*
|
2002-05-07 |
2002-06-12 |
Ferring Bv |
Pharmaceutical formulations
|
EP1572244A1
(en)
*
|
2002-12-11 |
2005-09-14 |
Chong Kun Dang Pharmaceutical Corp. |
Oral formulations for poorly absorptive hydrophilic drugs
|
WO2004069237A1
(en)
|
2003-02-07 |
2004-08-19 |
Prometic Biosciences Inc. |
Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
|
ITRM20030149A1
(it)
*
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico
|
CN1863510A
(zh)
|
2003-08-13 |
2006-11-15 |
比奥孔有限公司 |
用于治疗剂的微-粒子脂肪酸盐固体剂量制剂
|
JP2007509974A
(ja)
*
|
2003-10-31 |
2007-04-19 |
アルザ・コーポレーシヨン |
3−アミノプロピル−n−ブチルホスフィン酸の増大した吸収のための組成物および薬用量形態
|
JP5057779B2
(ja)
*
|
2004-03-24 |
2012-10-24 |
武田薬品工業株式会社 |
エマルション安定化製剤
|
CA2563533C
(en)
*
|
2004-04-15 |
2013-10-01 |
Shmuel A. Ben-Sasson |
Compositions capable of facilitating penetration across a biological barrier
|
US20070219131A1
(en)
*
|
2004-04-15 |
2007-09-20 |
Ben-Sasson Shmuel A |
Compositions capable of facilitating penetration across a biological barrier
|
US7645460B2
(en)
*
|
2004-05-24 |
2010-01-12 |
The Procter & Gamble Company |
Dosage forms of risedronate
|
US7645459B2
(en)
|
2004-05-24 |
2010-01-12 |
The Procter & Gamble Company |
Dosage forms of bisphosphonates
|
US20080286359A1
(en)
*
|
2004-05-24 |
2008-11-20 |
Richard John Dansereau |
Low Dosage Forms Of Risedronate Or Its Salts
|
US20080287400A1
(en)
*
|
2004-05-24 |
2008-11-20 |
Richard John Dansereau |
Low Dosage Forms Of Risedronate Or Its Salts
|
MX2007000883A
(es)
*
|
2004-07-19 |
2007-04-02 |
Biocon Ltd |
Conjugados de insulina-oligomero, formulaciones y usos de los mismos.
|
US20080214618A1
(en)
*
|
2004-08-23 |
2008-09-04 |
Auckland Uniservices Limited |
Gastric Therapies Amd Compositions Therefor
|
MY139644A
(en)
*
|
2005-02-17 |
2009-10-30 |
Palm Nutraceuticals Sdn Bhd |
Improving the quality of crude oils and fats and recovery of minor components
|
WO2007038796A1
(en)
*
|
2005-09-29 |
2007-04-05 |
Repros Therapeutics Inc. |
Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride
|
MX2008004674A
(es)
*
|
2005-10-13 |
2008-11-12 |
Biocon Ltd |
Proceso para la preparacion de conjugados de insulina.
|
US8920918B2
(en)
*
|
2005-10-31 |
2014-12-30 |
Kee Action Sports Technology Holdings, Llc |
Oil and polyethylene glycol fill material for use in paintball shells
|
US8846102B2
(en)
*
|
2006-03-30 |
2014-09-30 |
Engene, Inc. |
Non-viral compositions and methods for transfecting gut cells in vivo
|
CN101437522A
(zh)
|
2006-04-07 |
2009-05-20 |
默里昂研究Ⅲ有限公司 |
包含增强剂的固体口服剂型
|
US20070292512A1
(en)
*
|
2006-06-09 |
2007-12-20 |
Merrion Research Ii Limited |
Solid Oral Dosage Form Containing an Enhancer
|
EP2203181B1
(en)
*
|
2007-10-16 |
2018-02-14 |
Biocon Limited |
An orally administerable solid pharmaceutical composition and a process thereof
|
US20090271021A1
(en)
*
|
2008-04-28 |
2009-10-29 |
Popp Shane M |
Execution system for the monitoring and execution of insulin manufacture
|
WO2009137078A1
(en)
|
2008-05-07 |
2009-11-12 |
Merrion Research Iii Limited |
Compositions of peptides and processes of preparation thereof
|
GB0808537D0
(en)
*
|
2008-05-12 |
2008-06-18 |
Archimedes Dev Ltd |
Compositions
|
US20100105627A1
(en)
*
|
2008-09-17 |
2010-04-29 |
Paul Salama |
Pharmaceutical compositions and related methods of delivery
|
AU2015201581B2
(en)
*
|
2008-09-17 |
2017-03-09 |
Amryt Endo, Inc. |
Pharmaceutical Compositions and Related Methods of Delivery
|
US20100064927A1
(en)
*
|
2008-09-17 |
2010-03-18 |
Aldo Perrone |
Starch-based paintball fill material
|
EP2400851A4
(en)
*
|
2009-02-25 |
2012-09-05 |
Merrion Res Iii Ltd |
COMPOSITION AND ACTIVE COMPOSITION OF BISPHOSPHONATES
|
ES2969281T3
(es)
|
2009-06-18 |
2024-05-17 |
Acerus Pharmaceuticals Usa Llc |
Administración segura de desmopresina
|
CN102803842B
(zh)
|
2009-06-25 |
2015-07-01 |
皇家飞利浦电子股份有限公司 |
热管理设备
|
US20160016982A1
(en)
|
2009-07-31 |
2016-01-21 |
Thar Pharmaceuticals, Inc. |
Crystallization method and bioavailability
|
WO2011014766A2
(en)
|
2009-07-31 |
2011-02-03 |
Thar Pharmaceuticals, Inc. |
Crystallization method and bioavailability
|
US9169279B2
(en)
|
2009-07-31 |
2015-10-27 |
Thar Pharmaceuticals, Inc. |
Crystallization method and bioavailability
|
US20110142889A1
(en)
*
|
2009-12-16 |
2011-06-16 |
Nod Pharmaceuticals, Inc. |
Compositions and methods for oral drug delivery
|
WO2011084618A2
(en)
|
2009-12-16 |
2011-07-14 |
Nod Pharmaceuticals, Inc. |
Compositions and methods for oral drug delivery
|
MX2012007806A
(es)
*
|
2010-01-12 |
2012-08-01 |
Novo Nordisk As |
Composiciones farmaceuticas para administracion oral de peptidos de insulina.
|
US20110182985A1
(en)
*
|
2010-01-28 |
2011-07-28 |
Coughlan David C |
Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
|
WO2011120033A1
(en)
*
|
2010-03-26 |
2011-09-29 |
Merrion Research Iii Limited |
Pharmaceutical compositions of selective factor xa inhibitors for oral administration
|
US9340565B2
(en)
|
2010-11-24 |
2016-05-17 |
Thar Pharmaceuticals, Inc. |
Crystalline forms
|
EP2661273A4
(en)
|
2011-01-07 |
2014-06-04 |
Merrion Res Iii Ltd |
IRON PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION
|
CN107205948B
(zh)
|
2015-01-29 |
2021-12-14 |
诺和诺德股份有限公司 |
包含glp-1激动剂和肠溶衣的片剂
|
US10238709B2
(en)
|
2015-02-03 |
2019-03-26 |
Chiasma, Inc. |
Method of treating diseases
|
GB201511284D0
(en)
*
|
2015-06-26 |
2015-08-12 |
Univ Witwatersrand Jhb |
An oral pharmaceutical dosage form for the delivery of a peptide and/or protein
|
WO2017208070A1
(en)
|
2016-05-31 |
2017-12-07 |
Grünenthal GmbH |
Bisphosphonic acid and coformers with lysin, glycin, nicotinamide for treating psoriatic arthritis
|
GB201904771D0
(en)
|
2019-04-04 |
2019-05-22 |
Orexo Ab |
New pharmaceutical compositions
|
GB201904767D0
(en)
|
2019-04-04 |
2019-05-22 |
Orexo Ab |
New pharmaceutical compositions
|
US11141457B1
(en)
|
2020-12-28 |
2021-10-12 |
Amryt Endo, Inc. |
Oral octreotide therapy and contraceptive methods
|
US11896719B2
(en)
|
2022-01-24 |
2024-02-13 |
Calliditas Therapeutics Ab |
Pharmaceutical compositions
|